EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mohamed F. Ibrahim
Graham E. Venn
Christopher P. Young
David J. Chambers
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibrahim, M. F.
Right arrow Articles by Chambers, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibrahim, M. F.
Right arrow Articles by Chambers, D. J.

Eur J Cardiothorac Surg 1999;15:75-83
© 1999 Elsevier Science NL


A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution

Mohamed F. Ibrahim, Graham E. Venn, Christopher P. Young, David J. Chambers

Cardiac Surgical Research and Cardiothoracic Surgery, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK

Received 10 August 1998; received in revised form 2 November 1998; accepted 11 November 1998.

Corresponding author. Tel.: +44-171-261-0157; fax: +44-171-928-0658; e-mail: d.chambers@umds.ac.uk

Objective: Myocardial protection with blood cardioplegia during cardiac surgery is increasingly preferred, but few studies have compared the protective effects of crystalloid cardioplegia to the same solution with blood as the only variable. This clinical study compared the protective effects of crystalloid or blood-based St. Thomas' Hospital cardioplegic solution No. 1. Methods: Fifty higher risk patients undergoing elective coronary artery bypass surgery, with an ejection fraction less than 40%, were randomly allocated to receive cold (4°C) intermittent crystalloid St. Thomas' No. 1 cardioplegia (n=25), or a similar blood-based solution (n=25) with a haematocrit of 10–12%. We determined (1) peri-operative and post-operative arrhythmias, (2) left and right ventricular function (24 h) using the thermodilution technique, (3) left ventricular high-energy phosphate content sampled before ischaemia, the end of ischaemia and the end of bypass. Results: Pre-operative haemodynamic data, aortic cross-clamp and bypass times were similar in both groups of patients; there was no mortality. At the end of ischaemia there were no differences in ATP content between groups but creatine phosphate was maintained at a significantly (P<0.007) higher level in the blood-based St. Thomas' cardioplegia group than the crystalloid St. Thomas' cardioplegia group (20±2 (SE) vs. 13±1 µmol/g dry wt, respectively). Return to spontaneous sinus rhythm was significantly (P=0.002) increased in the blood-based St. Thomas' cardioplegia group (96%) compared to the crystalloid St. Thomas' cardioplegia group (60%). Early post-operative ventricular dysfunction occurred in both groups, but normal LV function (stroke work index) recovered significantly (P=0.043) more rapidly (by 2 h) in the blood-based St. Thomas' cardioplegia group of patients. Conclusions: In a higher risk (EF<40%) group of patients undergoing elective cardiac surgery, addition of blood to an established crystalloid cardioplegic solution significantly enhanced myocardial protection by reducing arrhythmias, improving rate of recovery of function and maintaining myocardial high-energy phosphate content during ischaemia.

Key Words: Patients • Cardioplegia • Myocardial protection • Function • Arrhythmias • Metabolism




This article has been cited by other articles:


Home page
ICVTSHome page
M. F. Ibrahim and A. A. Refaat
Long-term outcome after coronary artery bypass grafting in patients with left ventricular dysfunction: does the type of cardioplegia matter?
Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 498 - 498.
[Full Text] [PDF]


Home page
ICVTSHome page
S. Jacob, A. Kallikourdis, F. Sellke, and J. Dunning
Is blood cardioplegia superior to crystalloid cardioplegia?
Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 491 - 498.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Guru, J. Omura, A. A. Alghamdi, R. Weisel, and S. E. Fremes
Is Blood Superior to Crystalloid Cardioplegia?: A Meta-Analysis of Randomized Clinical Trials
Circulation, July 4, 2006; 114(1_suppl): I-331 - I-338.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. T. Bjerrum, M. J. Perko, and B. Beck
Myocardial oxygen tension during surgical revascularization: A clinical comparison between blood cardioplegia and crystalloid cardioplegia
Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 181 - 185.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Amark, H. Berggren, K. Bjork, A. Ekroth, R. Ekroth, K. Nilsson, and J. Sunnegardh
Blood Cardioplegia Provides Superior Protection in Infant Cardiac Surgery
Ann. Thorac. Surg., September 1, 2005; 80(3): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Ovrum, G. Tangen, S. Tollofsrud, R. Oystese, M. A. L. Ringdal, and R. Istad
Cold blood cardioplegia versus cold crystalloid cardioplegia: A prospective randomized study of 1440 patients undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 860 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. A. Khan, C. Bianchi, P. Voisine, J. Feng, J. Baker, M. Hart, M. Takahashi, G. Stahl, and F. W. Sellke
Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest
J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 602 - 608.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Kalawski, M. Majewski, E. Kaszkowiak, H. Wysocki, and T. Siminiak
Transcardiac Release of Soluble Adhesion Molecules During Coronary Artery Bypass Grafting: Effects of Crystalloid and Blood Cardioplegia
Chest, May 1, 2003; 123(5): 1355 - 1360.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. F. Kofoed, R. Bangsgaard, S. Carstensen, J. H. Svendsen, P. R. Hansen, H. Arendrup, B. Hesse, and H. Kelbaek
Prolonged ischemic heart disease and coronary artery bypass -- relation to contractile reserve
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 417 - 423.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.